TREA

77942356 - YUROXAN

Follow

Information

  • Trademark
  • 77942356
  • Serial Number
    77942356
  • Registration Number
    4040189
  • Filing Date
    February 23, 2010
    14 years ago
  • Registration Date
    October 18, 2011
    13 years ago
  • Transaction Date
    July 03, 2018
    6 years ago
  • Status Date
    May 25, 2018
    6 years ago
  • Published for Opposition Date
    August 02, 2011
    13 years ago
  • Location Date
    October 18, 2011
    13 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CHOSID, ROBIN S
  • Attorney Docket Number
    000337-018
    Attorney Name
    Adrienne L. White
    Law Office Assigned Location Code
    L20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
YUROXAN
Case File Statements
  • GS0051: Pharmaceutical and veterinary preparations for humans and animals, namely, medicines, vaccines, and serums for diagnostics, testing, prevention, treatment, and therapeutics, in particular medicines for treating cardiovascular illnesses, in particular hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for the treatment of immunological diseases, in particular autoimmune diseases in particular rheumatic disorders, polychondritis, Bechterew's disease, fibromyalgia and lupus erythematodes, rheumatoid arthritis, polyarthritis, Crohn's disease, and multiple sclerosis; medicines for treating skin diseases, in particular acne, actinic keratosis, alopecia, atopic dermatitis, Bowen's disease, cutaneous atopy, cutaneous T-cell lymphoma, Darrier's disease, Dartroud diathesis, dermatitis, eczema, genital herpes, genital warts, herpes, hyperkeratosis, hyperpigmentation, hyperplasia of the epidermis, hypopigmentation, ichthyosis, increased proliferation of skin cells, keloids, lentigo, lichen planus, melasma, molluscum contagiosum, mycosis fungoides, neoplasias, neurodermitis, pigmentation disorders, porokeratosis of Mibelli, psoriasis, removal of tattoos, rosacea, seborrhea, seborrheic keratosis, shingles, skin diseases related to inflammatory processes of skin cells, skin ulcers, vitiligo, warts, xerosis; medicines for treating tumourous diseases, in particular Astrocytomas, basal cell carcinomas, biliary cancers, bladder cancers, bone cancers, brain cancers, breast cancers, carcinomas, cervical cancers, cervical intraepithelial neoplasias, colorectal cancers, endocrine system cancers, ependymomas, epidermoid carcinomas, fibrosarcomas, gastric cancers, gastrointestinal cancers, glioblastomas, gynecologic cancers, head and neck cancers, hemangiomas, hepatomas, Hodgkin's lymphomas, Leukemia, liver cancers, lung cancers, lymphomas, medulloblastomas, meningiomas, mesothelaiomas, metastases, myelomas, neoplasias, neurectodermal cancers, neuroblastomas, neurofibromas, neurofibrosarcomas, neuronal cancers, non-Hodgkin's lymphomas, oligodendrogliomas, ovarian carcinoma, pancreatic cancers, pediatric cancers, penile cancer, pituitary adenomas, pleural cancers, renal cancer, sarcomas, Schwannomas, skin cancers, sqamous cell carcinomas, testicular cancers, thyroid cancers, thyroid tumors, urinary tract cancers, carcinoma of the prostate, melanoma, Kaposi's sarcoma, hepatocellular carcinoma; ALL OF THE ABOVE CONSISTING OF low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, T-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and plant extracts
  • TR0010: The wording "YUROXAN" has no meaning in a foreign language.
Case File Event Statements
  • 5/25/2018 - 6 years ago
    24 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 10/18/2016 - 8 years ago
    23 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 10/18/2011 - 13 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/2/2011 - 13 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/2/2011 - 13 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/28/2011 - 13 years ago
    19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 6/24/2011 - 13 years ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 6/22/2011 - 13 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/22/2011 - 13 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/22/2011 - 13 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/22/2011 - 13 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/22/2011 - 13 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/3/2011 - 14 years ago
    12 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 1/3/2011 - 14 years ago
    11 - PRIORITY ACTION E-MAILED Type: GPRA
  • 1/3/2011 - 14 years ago
    10 - PRIORITY ACTION WRITTEN Type: CPRA
  • 11/29/2010 - 14 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/29/2010 - 14 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/29/2010 - 14 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/29/2010 - 14 years ago
    6 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 5/29/2010 - 14 years ago
    5 - PRIORITY ACTION E-MAILED Type: GPRA
  • 5/29/2010 - 14 years ago
    4 - PRIORITY ACTION WRITTEN Type: CPRA
  • 5/27/2010 - 14 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/1/2010 - 14 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 2/26/2010 - 14 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP